SAINT-HERBLAIN, FRANCE: Valneva SE (Nasdaq: VALN) signed an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the company’s inactivated COVID-19 vaccine candidate VLA2001. This is the second purchase agreement Valneva has secured for VLA2001 since reporting positive data for its Phase 3 clinical trial Cov-Compare. VLA2001 is…